Abstract
High-throughput screening (HTS) is one of the most powerful approaches available for identifying new lead compounds for the growing catalogue of validated drug targets. However, just as virtual and experimental HTS have accelerated lead identification and changed drug discovery, they have also introduced a large number of peculiar molecules. Some of these have turned out to be interesting for further optimization, others to be dead ends when attempts are made to optimize their activity, typically after a great deal of time and resources have been devoted. Such false positive hits are still one of the key problems in the field of HTS and in the early stages of drug discovery in general. Many studies have been devoted to understanding the origins of false-positives, and the findings have been incorporated in filters and methods that can predict and eliminate problematic molecules from further consideration. This paper will focus on the structural classes and known mechanisms of nonleadlike false positives, together with experimental and computational methods for identifying such compounds.
Keywords: drug discovery, mechanism of false-positive inhibition, methods for detecting false positives, aggregate-based promiscuous inhibitors, reactive compounds, promiscuous inhibitors, more sophisticated, nonleadlike, indiscriminate, sulfhydryl group, metalloproteinase, allopurinol, Acylhydrazides, Azoalkanals, Epoxides, Nitroalkanes, Perhaloketones, Sulfonates, Thioepoxides, b-lactamase, dihydrofolate, Chymotrypsin, chicken DHFR, stoichiometry, CAC, hydrogen-deuterium, nicardipine, SRR (structure-reactivity relationship), Delavirdine, Glyburide, Oxaprozin, Clioquinol, Hydroxyphenilhydrazones, 2-amino-3-carbonyl tiophenes, 2-hydroxyphenylhydrazones, photoactive dyes, perplexing, Shoichet, CHAPS, Enzyme Concentration, baseline enzyme, Incubation Effect, cysteine proteases, red-horseradish, prioritization, angiogenin, NMR, Light Scattering, microsecond, Plasmon Resonance, optical biosensor surface, pronounced capillarity, tetraiodophenolphthalein, ALARM NMR, omeprazole, thiol-reactive, WaterLOGSY spectrum, misinformed, CLND, HTS, PAINS
Current Medicinal Chemistry
Title: False Positives in the Early Stages of Drug Discovery
Volume: 17 Issue: 34
Author(s): R. Sink, S. Gobec, S. Pecar and A. Zega
Affiliation:
Keywords: drug discovery, mechanism of false-positive inhibition, methods for detecting false positives, aggregate-based promiscuous inhibitors, reactive compounds, promiscuous inhibitors, more sophisticated, nonleadlike, indiscriminate, sulfhydryl group, metalloproteinase, allopurinol, Acylhydrazides, Azoalkanals, Epoxides, Nitroalkanes, Perhaloketones, Sulfonates, Thioepoxides, b-lactamase, dihydrofolate, Chymotrypsin, chicken DHFR, stoichiometry, CAC, hydrogen-deuterium, nicardipine, SRR (structure-reactivity relationship), Delavirdine, Glyburide, Oxaprozin, Clioquinol, Hydroxyphenilhydrazones, 2-amino-3-carbonyl tiophenes, 2-hydroxyphenylhydrazones, photoactive dyes, perplexing, Shoichet, CHAPS, Enzyme Concentration, baseline enzyme, Incubation Effect, cysteine proteases, red-horseradish, prioritization, angiogenin, NMR, Light Scattering, microsecond, Plasmon Resonance, optical biosensor surface, pronounced capillarity, tetraiodophenolphthalein, ALARM NMR, omeprazole, thiol-reactive, WaterLOGSY spectrum, misinformed, CLND, HTS, PAINS
Abstract: High-throughput screening (HTS) is one of the most powerful approaches available for identifying new lead compounds for the growing catalogue of validated drug targets. However, just as virtual and experimental HTS have accelerated lead identification and changed drug discovery, they have also introduced a large number of peculiar molecules. Some of these have turned out to be interesting for further optimization, others to be dead ends when attempts are made to optimize their activity, typically after a great deal of time and resources have been devoted. Such false positive hits are still one of the key problems in the field of HTS and in the early stages of drug discovery in general. Many studies have been devoted to understanding the origins of false-positives, and the findings have been incorporated in filters and methods that can predict and eliminate problematic molecules from further consideration. This paper will focus on the structural classes and known mechanisms of nonleadlike false positives, together with experimental and computational methods for identifying such compounds.
Export Options
About this article
Cite this article as:
Sink R., Gobec S., Pecar S. and Zega A., False Positives in the Early Stages of Drug Discovery, Current Medicinal Chemistry 2010; 17 (34) . https://dx.doi.org/10.2174/092986710793348545
DOI https://dx.doi.org/10.2174/092986710793348545 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges
Current Medicinal Chemistry Functional Non-Synonymous Polymorphisms Prediction Methods: Current Approaches and Future Developments
Current Medicinal Chemistry Cartilage and Bone Extracellular Matrix
Current Pharmaceutical Design Current Phthalocyanines Delivery Systems in Photodynamic Therapy: An Updated Review
Current Medicinal Chemistry Nitroxyl (HNO): A Possible Strategy for Fighting Cancer
Current Topics in Medicinal Chemistry Novel uses of Imaging in AF Ablation
Recent Patents on Cardiovascular Drug Discovery Synthesis and Cytotoxic Evaluation of Novel Symmetrical Taspine Derivatives as Anticancer Agents
Medicinal Chemistry Hypertension, Cognitive Impairment and Dementia: An Epidemiological Perspective
Current Hypertension Reviews Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets <i>In vivo</i> Anticancer Potential of Hydroxamic Acid Derivatives
Current Topics in Medicinal Chemistry Psychological Stress and the Development of Heart Disease
Current Psychiatry Reviews Recent Developments on Phenstatins as Potent Antimitotic Agents
Current Medicinal Chemistry Recent Developments in Nano-Drug Delivery Systems Loaded by Phytochemicals for Wound Healing
Mini-Reviews in Medicinal Chemistry Development of Crystalline Cellulosic Fibres for Sustained Release of Drug
Current Topics in Medicinal Chemistry Investigating the Preventive Effects of 99Tc-Methylenediphosphonate on a Glucocorticoid-Induced Osteoporosis Rabbit Model
Current Topics in Medicinal Chemistry Targeting Mitochondrial Oxidative Stress Through Lipoic Acid Synthase: A Novel Strategy to Manage Diabetic Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Emerging Potential of Citrus Flavanones as an Antioxidant in Diabetes and its Complications
Current Topics in Medicinal Chemistry Discovery of Thiazole Based Bis Heterocyclic System for Anti- Inflammatory Potential
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Erythropoietin: New Horizon in Cardiovascular Medicine
Recent Patents on Cardiovascular Drug Discovery Recent Advances in the Discovery of Tissue Factor/Factor VIIa Inhibitors and Dual Inhibitors of Factor VIIa/Factor Xa
Current Pharmaceutical Design